Your browser doesn't support javascript.
loading
Who really benefits from intraperitoneal chemotherapy for advanced ovarian cancer? A treatment-free survival analysis of the AICE trial.
Xiang, Libing; Shen, Lina; Chen, Yulian; Guo, Yi; Jiang, Rong; Zhang, Wen; Jia, Huixun; Wu, Zhenyu; Zang, Rongyu.
Afiliación
  • Xiang L; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shen L; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen Y; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Guo Y; Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China.
  • Jiang R; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang W; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Jia H; Clinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wu Z; Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China.
  • Zang R; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
BJOG ; 129 Suppl 2: 32-39, 2022 11.
Article en En | MEDLINE | ID: mdl-36485070

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: BJOG Asunto de la revista: GINECOLOGIA / OBSTETRICIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: BJOG Asunto de la revista: GINECOLOGIA / OBSTETRICIA Año: 2022 Tipo del documento: Article País de afiliación: China